Somatus
PrivateLast Round
Series E
Feb 23, 2022
Est. Valuation
$2.5B
Total Funding Raised
$465.12M
Company Overview
Somatus is a healthcare company that provides value-based kidney care services designed to delay or prevent the progression of chronic kidney disease to end-stage renal disease.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Patient Engagement, Vertical SaaS
Business Model
B2B2C
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Price History
Caplight MarketPrice™ estimate for Somatus, published with a 90-day delay.
Caplight MarketPrice™
$827.86
per share, as of June 2026
-6.7%
9-month change
Caplight MarketPrice™ is an estimate of private secondary market pricing, shown here on a delayed basis for illustrative purposes only. It may be incomplete, is subject to change, and may not be relied upon for any purpose or considered investment advice.
Somatus Comparables
Compare Somatus with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Strive Health | 94% | |
| Monogram Health | 93% | |
| Evergreen Nephrology | 83% |
Somatus Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series E | Feb 23, 2022 | ||||
| Series D | Jun 15, 2021 | ||||
| Series C | Jun 23, 2020 | ||||
| Series B | Apr 11, 2018 | ||||
| Series A | May 12, 2017 |
Key People
Founding team and executive leadership
Somatus Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series D, Series E, Series C |
| Deerfield Management | Series D, Series E, Series C |
| Town Hall Ventures | Series C, Series B |
| RA Capital Management | Series E |
| Blue Cross Blue Shield Association | Series E, Series C |
| Fidelity Management & Research Company | Series E |
| GIC Private Limited | Series E |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 23, 2022
$325M round led by Wellington Management.
- Jun 15, 2021
$60M round with participation from Optum Ventures and Deerfield Management.
Recent news
Latest coverage and updates
- opens_new_locationAug 26, 2026
Somatus opened new location in Silver Spring, Maryland, United States, Northern America, Americas on Aug 26th '26.
Somatus Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Somatus's valuation, stock price, and market status.
Is Somatus a public or private company?
Somatus is a private company.
What is the current stock price of Somatus?
Somatus is a private company with no public stock price. Caplight tracks Somatus's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Somatus worth (valuation)?
Somatus's valuation is estimated at $2.5B based on funding round data.
Can I buy Somatus stock?
Somatus shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Somatus's last funding round?
Somatus's most recent funding round was Series E on February 23, 2022.
Who are the main investors in Somatus?
Key investors in Somatus include Longitude Capital, Deerfield Management, Flare Capital Partners, Optum Ventures, Wellington Management.
Will Somatus IPO soon?
No public IPO plans have been announced for Somatus.
How can I track Somatus secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Somatus's secondary market activity and sign up for updates.